To assess the ''real-world'' compliance with risk-and culture-based strategies to prevent early-onset group B streptococcal disease.
INTRODUCTION
Group B streptococcal sepsis is a leading cause of neonatal sepsis in the United States. The incidence of early-onset group B streptococcal disease defined as group B streptococcal disease in a neonate less than 7 days old has declined from 1.7/1000 live births in 1993 to 0.6/1000 in 1998. 1 This 65% decline in early-onset group B streptococcal cases has occurred during the implementation of strategies that use intrapartum antibiotic prophylaxis for women at risk.
Early-onset group B streptococcus occurs through vertical transmission of the organism during the intrapartum period. Factors associated with an increased risk of early-onset group B streptococcal disease include: rupture of membranes >18 hours, intrapartum fever, group B streptococcal bacteriuria, prematurity, low maternal group B streptococcal antibody, and a previous sibling with group B streptococcal disease. [2] [3] [4] [5] [6] Randomized clinical trials have shown that intrapartum treatment of women who are group B streptococcal carriers prevents the majority of early-onset group B streptococcal cases. 7 Recognizing these results, professional organizations have recommended two strategies to reduce group B streptococcal disease. The American College of Obstetricians and Gynecologists (ACOG) proposed intrapartum antibiotic prophylaxis for all women in labor with identifiable risk factors associated with an increased risk for delivering babies who will develop group B streptococcal disease. 8 In 1996, the Centers for Disease Control (CDC) recommended a culture-based approach that required obtaining group B streptococcal cultures on prenatal patients at 35 to 37 weeks gestation and intrapartum antibiotic prophylaxis for all group B streptococcal positive women. Under this strategy, treatment is also recommended for women delivering prior to 37 weeks, women with group B streptococcal bacteriuria during pregnancy, or a previously affected child. 9 The CDC and ACOG recommended that all obstetrical practices adopt either the risk-or culture-based approach for the prevention of early-onset group B streptococcal disease. A recent survey of ACOG fellows revealed that 95% of them had adopted a group B streptococcal prevention strategy although the majority had adopted a strategy combining culture-based and risk-based approaches. 10 At the academic hospitals in our study, the risk-based strategy was implemented at one and the culture-based strategy at the other in August 1997. At the community hospital, obstetrical practices chose either the risk-or culture-based strategy.
Unlike prior evaluations of compliance with these strategies, we reviewed antenatal data that allowed us to identify all risk factors for group B streptococcus. 11, 12 Furthermore ''real world'' compliance allowed us to make observations about application of these strategies in clinical settings and provide more information about practice than previously identified through surveys. 10 Our aim was to evaluate the intrapartum compliance. For the culture-based protocol, compliance was defined as culture positive receiving antibiotics or culture unavailable but risk factor positive receiving antibiotics. For the risk-based protocol, compliance was defined as risk factor positive receiving antibiotics. In addition, we evaluated other lapses in the intended strategies such as use of antibiotics without risk factors or positive culture, inappropriate timing of cultures, and less than 4 hours of antibiotics.
METHODS
We retrospectively collected data from prenatal and labor and delivery records on maternal colonization status, antepartum and intrapartum risk factors for group B streptococcal disease such as group B streptococcal bacteriuria, fever in labor, and rupture of membranes >18 hours, intrapartum antibiotic prophylaxis, and adverse drug reactions of all full-term women who labored at the academic institutions between January and February 1998. We collected the same information at the community hospital between January and March 1998 over a longer time frame because of a lower delivery volume. We chose only full-term laboring women to avoid assessing compliance with intrapartum antibiotic prophylaxis for cesarean delivery where the guidelines are unclear. Furthermore, all institutions were using a protocol such that preterm infants automatically received antibiotics for group B streptococcal prophylaxis and some for preterm premature rupture of the membranes.
At the academic hospital using the risk-based strategy, there is one physician group and one midwifery group providing care to the entire population. Medical records and laboratory data are available through computer access. At the academic hospital using the culture-based strategy, we included only a subset of practitioners (four physician groups and one midwifery group) because they used the hospital microbiology lab; therefore, prenatal culture information was computerized and available on labor and delivery. At the community hospital, women were counted in the culture-or risk-based strategy based on the intended strategy for their provider practice. All practices used the hospital laboratory, thus computer access to laboratory results was available in labor.
For a woman treated under the risk-based strategy, compliance with that strategy was defined as the woman having fever Z100.4, rupture of membranes >18 hours, group B streptococcal bacteriuria, or a previous infant with group B streptococcal disease and receiving intrapartum antibiotic prophylaxis. For a woman treated under the culture-based strategy, compliance with that strategy was defined as having a positive culture taken at 35 to 37 weeks gestation and receiving intrapartum antibiotic prophylaxis. In addition, if a woman in the culture-based strategy had no culture information available at delivery but received intrapartum antibiotic prophylaxis based on having a risk factor, it was considered compliant as the CDC guidelines recommend treating those women by risk factors in labor. Noncompliance was considered to occur when (1) a culture-positive woman was not treated with antibiotics; (2) a culture was done before 35 to 37 weeks gestation; or (3) risk factors were present and treatment not given.
First, we compared overall compliance with the risk-and culture-based strategies. Then we compared compliance and lapses by site. We compared differences in proportions of categorical variables using the w 2 or Fischer exact test when appropriate.
RESULTS
At the community hospital, we included all four physician practices and one midwifery practice; three risk-based and two culture-based. Both culture-based practices used the hospital microbiology laboratory and should have had the culture information available at delivery by computer. There were 335 records abstracted at the academic hospital using the risk-based approach; 57/335 (17%) having any risk factor. There were 314 records abstracted at the academic hospital using the culture-based approach; 58/314 (18.5%) had positive cultures at 35 to 37 weeks. There were 17/314 (5.4%) women with no cultures documented. At the community hospital, there were 101 records abstracted from the practices using the culture-based strategy; 12/101 (11.9%) had positive cultures and 22 (21.8%) had no documentation in the medical record that cultures had been done. Six (5.9%) had cultures performed in the first trimester; for purposes of compliance, these women are not considered as having been cultured. Also, at the community hospital there were 170 records abstracted from the groups using the risk-based approach and 22/170 (12.9%) had any risk factor.
Overall, there were 505 women in the risk-based strategy, 79 (15.6%) had risk factors. There were 415 women in the culturebased strategy, 70 (16.9%) had positive cultures and another 39 (9.4%) with no culture information documented either prenatally or in labor.
In the risk-based strategy, 100% of women with fever received antibiotics while 26/28 (92.9%) with group B streptococcal bacteriuria and only 32/37 (86.5%) women with rupture of membranes >18 hours received intrapartum antibiotic prophylaxis (Table 1) . Of women in the culture-based strategy, 67/70 (95.7%) with positive cultures received intrapartum antibiotic prophylaxis and we assume another 39 were placed in the risk-based strategy when their cultures were not documented. Of those, 8/39 (20.5%) had risk factors and all eight received intrapartum antibiotic prophylaxis. Overall, compliance with the risk-based strategy was 72/79 (91.1%) versus 75/78 (96.2%) with the culture-based strategy. There was no statistically significant difference in compliance between these approaches ( p ¼ 0.3). However, if we compare compliance with the intended strategy by site, the overall compliance was 52/57 (91.2%) for the academic hospital using the risk-based strategy, 61/61 (100%) for the academic hospital using the culture-based strategy, 14/17 (82.4%) for the community practices using the culture-based strategy, and 20/22 (90.9%) for the community practices using the risk-based strategy.
At the academic site, the cultures were not documented in 17/314 (5.4%) of cases. At the community site, there was no documentation of cultures done in 22/101 (21.8%) cases ( p<0.0001). We assume that when cultures were not documented as being done at 35 to 37 weeks and not documented in labor, cultures were not obtained; therefore, compliance for these patients was evaluated based on risk factors. There were 3/17 cases that had risk factors at the academic site using the culture-based approach and all received antibiotics. Likewise, 5/22 had risk factors at the community site using the culture-based approach and all received intrapartum antibiotic prophylaxis.
We examined noncompliance with the intended group B streptococcal protocols ( Table 2 ). There were three cases (1.1%) at the academic hospital using the risk-based approach and two (1.4%) at the community site using the risk-based approach where antibiotics were given and no risk factor could be identified. In contrast, there were two cases (0.78%) at the academic site and five cases (5.6%) at the community site where the cultures were negative and antibiotics were given. In four out of these five cases at the community site using the culture-based approach, women had rupture of membranes >18 hours. In the remaining cases, no risk factor could be identified. The cultures were done at 35 to 37 weeks in all cases at the academic site using the culture-based approach. However, 6/101 (5.9%) cases at the community site using the culture-based approach were done in the first trimester.
Antibiotics for group B streptococcal prophylaxis were used in 52/335 (15.5%) of women at the academic hospital using the riskbased approach, in 61/314 (19.0%) of women at the academic hospital using the culture-based approach, and in 14/101(13.9%) of culture-based cases and 20/170 (11.8%) of risk-based cases at the community hospital. The most common antibiotic used for intrapartum prophylaxis, excluding fever, at all institutions was penicillin in 112/147 cases who received antibiotics (76.2%). For penicillin allergic patients, clindamycin was the alternative drug of choice in 22/147 cases (15.0%). There were rare instances where ampicillin was used and there was no instance where cephalosporins were used. There was one adverse drug reaction, which was a rash to penicillin. We knew the exact time of antibiotic administration in 96.6% of the 147 patients receiving antibiotics for group B streptococcal prophylaxis. Of those 142 patients in whom the exact time of antibiotic administration and delivery time were documented, we found that at least 4 hours of intrapartum antibiotic prophylaxis was given in 37/50 (74%) of cases where group B streptococcal prophylaxis was indicated at the 
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Compliance with Group B Streptococcal Prophylaxis academic site using the risk-based strategy versus 47/59 (79.7%) of cases at the academic site using the culture-based strategy. At the community hospital, 13/20 (65%) of cases using the risk-based approach versus 7/13 (54.5%) of cases using the culture-based approach received at least 4 hours of intrapartum antibiotic prophylaxis. Overall, the ability to administer four hours of intrapartum antibiotic prophylaxis was higher in the academic sites versus the community site (p ¼ 0.06). Of those women who got less than 4 hours intrapartum antibiotic prophylaxis, 18/38 (47.4%) had labor less than five hours and another 8 women developed fever Z100.4, which prompted antibiotic use. Therefore, half of the women were in labor long enough with risk factors identified or with positive cultures to receive at least 4 hours of antibiotics.
DISCUSSION
At the time this study was conducted, the optimal approach to group B streptococcal prophylaxis had not been established. Therefore, we had the unique ability to compare two strategies in academic institutions and two strategies within the same community hospital setting. In recent months, the CDC has conducted a surveillance study that suggests the culture-based approach is superior to the risk-based approach to decrease the number of early-onset group B streptococcal cases. 13 Our intention was to evaluate those cases in which there may be confusion because prophylaxis is not recommended for all patients (e.g. term patients); therefore, we excluded cases of preterm labor. We also excluded patients who underwent elective cesarean delivery because the existing strategies in 1998 outlined by ACOG and the CDC did not clearly address group B streptococcal prophylaxis prior to cesarean delivery. We found that compliance with the risk-based approach was less than the culture-based approach although not statistically significantly different. Compliance varied based on practice setting where compliance in selected practices of the academic site using culture was superior to the community site.
Other studies have evaluated compliance with selected risk factors. Lieu et al. 11 evaluated two HMO hospitals in California and found 40% of women with prolonged rupture of membranes received intrapartum antibiotic prophylaxis. Factor et al. 12 reported that compliance at Jackson Memorial Hospital improved from 20 to 70% for women with rupture of membranes >18 hours and from 13 to 42% for preterm deliveries between 1992 and 1995. Neither study reported compliance with the other important factors; thus, overall compliance could not be determined. As in our sites, rupture of membranes >18 hours was the most common missed opportunity where 13.5% of our cases did not receive intrapartum antibiotic prophylaxis.
Studies that evaluated compliance with the culture-based approach revealed an overall compliance of 86 to 94.4%. [14] [15] [16] We found similarly high rates of screening and intrapartum antibiotic prophylaxis at the academic hospital 61/61 (100%) but less intrapartum antibiotic prophylaxis at the community hospital 14/20 (82.4%). Main et al. noted that in a culture-based system, only 9% of women had risk factors applied in labor because of lack of culture information. 16 At the academic site, 17/314 (5.4%) of women had no culture information available. In contrast, at our community hospital, 22/101 (21.8%) of patients had no culture information documented at the time of labor. The reason for this number of patients without cultures could not be definitively determined. It could be that cultures were not done because of provider error or missed patient appointments, cultures done but not completed before labor, or cultures in the computer and not checked by the provider. As a recent ACOG survey noted, we too found that there was a mixing of the two strategies. 10 There were women who received antibiotics because of prolonged ruptured membranes who had known negative cultures at the time of labor and delivery. We can only speculate that physicians were uncomfortable despite negative cultures with patients who still had perceived risk factors.
Our data show that using the same narrow definition of compliance as other authors, which includes culture positive/ antibiotics given or risk factors positive/antibiotics given, the overall compliance of these strategies is similar. However, when we evaluate ''real-world'' compliance, we are able to demonstrate that evaluating all risk factors, including lapses in the intended protocol, occurred more frequently with certain risk factors such as rupture of membranes >18 hours. More importantly, our data shows that evaluating ''real-world'' application of these strategies demonstrates the complexity of the culture-based approach. Thus, failure to perform the culture at the appropriate gestational age is a potentially harmful breach of the protocol in that the sensitivity of the culture is diminished if the culture is done <5 weeks from delivery. 17 Lack of culture data in labor shifts women into the riskbased strategy and decreases the benefits of using the culture-based strategy.
Our data also indicate that obstetric practices have complied with the recommendation to use penicillin as the narrowest spectrum for group B streptococcal prophylaxis. However, clindamycin appears to be the alternative of choice in penicillin allergic women. As more clindamycin-resistant isolates emerge, alternatives such as first-generation cephalosporins are preferable. 18, 19 This will be an important area of education for physicians, as antibiotic recommendations have changed. 20 We also found that the majority of patients received more than four hours of intrapartum antibiotic prophylaxis at the academic sites and fewer women received more than 4 hours at the community hospital.
One limitation of our study was that we were unable to evaluate directly all of the barriers to implementation. Full implementation of the culture-based strategy relies on obtaining a culture from the lower third of the vagina and rectum using specific transport media and using selective broth to maximize the culture positivity rate. In addition, communication of the culture results at labor to allow appropriate intrapartum antibiotic prophylaxis is indicated. For instance, we know that appropriate culture transport media or laboratory culture techniques were applied. However, we do not know if the culture was done from the lower vagina and rectum. We also do not know the precise reason that a number of women had no documented culture results in labor.
Our data suggest that there are several ways in which institutions and practices can improve their compliance with either strategy that is chosen although the newest CDC guidelines suggest using only the culture-based approach. 20 It is very possible that a single strategy per labor and delivery site may enhance compliance in that all practitioners would look for culture information. Patient and physician education might decrease the number of women arriving at delivery with no culture information known and subsequently managed using the risk-based protocol. Furthermore, computerized prenatal records and lab data would aid the identification of prenatal risk factors such as group B streptococcal bacteriuria and culture results.
Strategies to improve implementation may include group B streptococcal status or group B streptococcal risk factor as a check box on labor and delivery admission forms and preprinted orders for intrapartum antibiotic prophylaxis. Those orders might trigger intrapartum antibiotic prophylaxis if group B streptococcal bacteriuria noted in pregnancy and broad-spectrum antibiotics for fever Z100. 4 . If the culture information was checked upon the patient's arrival and antibiotics were instituted immediately, more women might receive >4 hours of intrapartum antibiotic prophylaxis. In addition, patient education about the prenatal risk factors or culture results would encourage women to alert providers to the need for intrapartum antibiotic prophylaxis upon their arrival in labor.
Our data suggest that compliance with the culture-based strategy is best in a system with an integrated prenatal record, laboratory information, and labor and delivery activity. Deviations from the culture-based strategy as we have pointed out may hamper the benefits of this strategy. As many practices transition to using a culture-based strategy, our evaluation of three ''realworld'' practice settings with differing approaches highlights some areas where specific improvement efforts, which may include patient and physician education about both cultures and risk factors, would enhance implementation and ''real-world'' compliance with the intended strategy.
